DiaMedica Therapeutics (NASDAQ:DMAC) Issues Earnings Results
DiaMedica Therapeutics (NASDAQ:DMAC – Get Free Report) issued its quarterly earnings results on Wednesday. The company reported ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by ($0.02), FiscalAI reports. DiaMedica Therapeutics Trading Up 4.3% DMAC stock traded up $0.27 on Wednesday, hitting $6.52. 184,771 shares of the company’s stock […]
6 May 22:48 · The Cerbat Gem